{"resourceType": "Evidence", "id": "47758", "meta": {"versionId": "15", "lastUpdated": "2023-12-06T17:54:20.468Z", "profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/comparative-evidence", "http://hl7.org/fhir/uv/ebm/StructureDefinition/single-study-evidence"]}, "url": "https://fevir.net/resources/Evidence/47758", "title": "ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Schauer 2012 (STAMPEDE) trial", "status": "active", "date": "2022-05-29T11:09:57.278Z", "useContext": [{"code": {"system": "https://fevir.net/resources/CodeSystem/179423", "code": "evidence-communication", "display": "Evidence Communication"}, "valueCodeableConcept": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "ComparativeEvidence", "display": "ComparativeEvidence"}]}}, {"code": {"system": "https://fevir.net/resources/CodeSystem/179423", "code": "evidence-communication", "display": "Evidence Communication"}, "valueCodeableConcept": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "SingleStudyEvidence", "display": "SingleStudyEvidence"}]}}], "description": "Mean HbA1c at 12 months in Schauer 2012 was 6.5% in Surgery group (n = 99) and 7.5% in Medical/Lifestyle group (n = 41), mean difference -1.00% (95% CI -1.58% to -0.42%)", "variableDefinition": [{"description": "140 obese patients with uncontrolled T2DM", "variableRole": "population", "observed": {"type": "Group", "display": "Schauer 2012 Trial Enrollment Group"}}, {"description": "Roux-en-Y Gastric Bypass or Sleeve Gastrectomy plus medical therapy vs. medical treatment (Medical therapy alone)", "variableRole": "exposure", "comparatorCategory": "medical treatment", "observed": {"reference": "EvidenceVariable/172478", "type": "EvidenceVariable", "display": "GroupAssignment: Roux-en-Y gastric bypass vs. medical treatment"}}, {"description": "HbA1c at 12 months", "variableRole": "outcome", "observed": {"reference": "EvidenceVariable/173243", "type": "EvidenceVariable", "display": "OutcomeVariable: HbA1c at 12 months"}}], "synthesisType": [{"coding": [{"system": "http://terminology.hl7.org/CodeSystem/synthesis-type", "code": "NotApplicable", "display": "not applicable"}]}], "statistic": [{"description": "mean difference -1.00% (95% CI -1.58% to -0.42%)", "note": [{"text": "Mean HbA1c at 12 months in Schauer 2012 was 6.5% in Surgery group (n = 99) and 7.5% in Medical/Lifestyle group (n = 41)"}], "statisticType": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/statistic-type", "code": "0000457", "display": "Mean Difference"}]}, "quantity": {"value": -1, "unit": "%", "system": "http://unitsofmeasure.org", "code": "%"}, "sampleSize": {"numberOfParticipants": 140, "knownDataCount": 140}, "attributeEstimate": [{"description": "95% CI  -1.58% to -0.42%", "type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type", "code": "C53324", "display": "Confidence interval"}]}, "level": 0.95, "range": {"low": {"value": -1.58, "unit": "%", "system": "http://unitsofmeasure.org", "code": "%"}, "high": {"value": -0.42, "unit": "%", "system": "http://unitsofmeasure.org", "code": "%"}}}]}], "publisher": "Computable Publishing LLC", "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "https://fevir.net/FOI", "value": "47758", "assigner": {"display": "Computable Publishing LLC"}}], "contact": [{"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}], "author": [{"name": "Brian S. Alper"}], "studyDesign": [{"coding": [{"system": "https://fevir.net/sevco", "code": "SEVCO:01003", "display": "randomized assignment"}]}], "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "code": "active", "display": "Active"}]}}], "relatesTo": [{"type": "derived-from", "targetAttachment": {"url": "https://diabetesjournals.org/care/article/39/6/861/29305/Metabolic-Surgery-in-the-Treatment-Algorithm-for", "title": "Figure 2C Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations [Journal Article]. Contributors: Francesco Rubino, David M Nathan, Robert H Eckel, Philip R Schauer, K George M M Alberti, Paul Z Zimmet, Stefano Del Prato, Linong Ji, Shaukat M Sadikot, William H Herman, Stephanie A Amiel, Lee M Kaplan, Gaspar Taroncher-Oldenburg, David E Cummings, Delegates of the 2nd Diabetes Surgery Summit. In: Diabetes care, PMID 27222544. Published June 2016. Available at: https://pubmed.ncbi.nlm.nih.gov/27222544/."}, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relatesto-classifier", "valueCodeableConcept": {"text": "data source"}}]}], "citeAs": "ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Schauer 2012 (STAMPEDE) trial [Evidence]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 47758. Revised 2022-05-29. Available at: https://fevir.net/resources/Evidence/47758. Computable resource at: https://fevir.net/resources/Evidence/47758.", "name": "ComparativeEvidence_Mean_difference_in_HbA1c_between_Surgery_and_Medical_Lifestyle_groups_in_Schauer_2012_STAMPEDE_trial"}